Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019

Figure 1 Global disease burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease by countries and territories for both sexes combined. A: The age-standardized prevalence rate (ASPR) of cirrhosis and other chronic liver diseases (COCLDs) due to nonalcoholic fatty liver disease (NAFLD) in 2019; B: The percentage change in prevalence cases of COCLDs due to NAFLD between 1990 and 2019; C: The estimated annual percentage change of COCLDs due to NAFLD ASPR from 1990 to 2019. EAPC: Estimated annual percentage change.

Figure 2 Cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease at the global and regional levels from 1990 to 2019. A: Prevalence number; B: Death number; C: All-age prevalence rate; D: All-age death rate.

Figure 3  Age-standardized prevalence rate for cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease by region and sex, 2019.

Figure 4  All-age numbers and rates of deaths for cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease in 2019 are illustrated by sex for females and males.

Figure 5 Age-standardized disability-adjusted life years rate of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease by sociodemographic index globally and in 21 regions, 1990-2019. SDI: Sociodemographic index; DALYs: Disability-adjusted life years.

Figure 6 Age-standardized disability-adjusted life years rate of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease by sociodemographic index in 204 countries and territories, 2019. DALYs: Disability-adjusted life years; SDI: Sociodemographic index.